These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 2512985)
21. Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor. Triggiani M; Connell TR; Chilton FH J Immunol; 1990 Oct; 145(7):2241-8. PubMed ID: 2118931 [TBL] [Abstract][Full Text] [Related]
22. The metabolism of 1-acyl-PAF in rabbit platelets and its possible interaction with PAF. Touqui L; Silva CS; Vargaftig BB Lipids; 1991 Dec; 26(12):992-6. PubMed ID: 1819755 [TBL] [Abstract][Full Text] [Related]
23. Human and rabbit platelets form platelet-activating factor in response to calcium ionophore. Alam I; Smith JB; Silver MJ Thromb Res; 1983 Apr; 30(1):71-9. PubMed ID: 6407140 [TBL] [Abstract][Full Text] [Related]
24. Stimulation of the de novo pathway for the biosynthesis of platelet-activating factor (PAF) via cytidylyltransferase activation in cells with minimal endogenous PAF production. Blank ML; Lee YJ; Cress EA; Snyder F J Biol Chem; 1988 Apr; 263(12):5656-61. PubMed ID: 2833508 [TBL] [Abstract][Full Text] [Related]
25. Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds. Hogaboam CM; Donigi-Gale D; Shoupe TS; Bissonnette EY; Befus AD; Wallace JL Br J Pharmacol; 1992 Jan; 105(1):87-92. PubMed ID: 1596692 [TBL] [Abstract][Full Text] [Related]
26. Antigen-and ionophore-stimulated synthesis of platelet-activating factor by the cloned mast cell line, MC9. Musch MW; Billah MM; Siegel MI Biochem Biophys Res Commun; 1987 May; 144(3):1243-50. PubMed ID: 3107564 [TBL] [Abstract][Full Text] [Related]
27. Paf-acether formation and arachidonic acid freeing from platelet ether-linked glyceryl-phosphorylcholine. Chignard M; Le Couedic JP; Coëffier E; Benveniste J Biochem Biophys Res Commun; 1984 Oct; 124(2):637-43. PubMed ID: 6437404 [TBL] [Abstract][Full Text] [Related]
28. Turnover of arachidonic acid in the major diacyl and ether phospholipids of human platelets. Purdon AD; Smith JB J Biol Chem; 1985 Oct; 260(23):12700-4. PubMed ID: 3930502 [TBL] [Abstract][Full Text] [Related]
29. Effect of immunological stimulation on the production of platelet-activating factor by rat peritoneal cells: its relevance to anaphylactic reactions. Pellon MI; Fernandez-Gallardo S; Gijon MA; Garcia MC; Liu FT; Sanchez Crespo M Immunopharmacology; 1993; 26(1):73-82. PubMed ID: 8407286 [TBL] [Abstract][Full Text] [Related]
31. Stimulation of platelet-activating factor synthesis by progesterone and A23187 in human spermatozoa. Baldi E; Falsetti C; Krausz C; Gervasi G; Carloni V; Casano R; Forti G Biochem J; 1993 May; 292 ( Pt 1)(Pt 1):209-16. PubMed ID: 8503848 [TBL] [Abstract][Full Text] [Related]
32. Stimulation of platelet-activating factor synthesis by a nonmetabolizable bioactive analog of platelet-activating factor and influence of arachidonic acid metabolites. Tessner TG; O'Flaherty JT; Wykle RL J Biol Chem; 1989 Mar; 264(9):4794-9. PubMed ID: 2538461 [TBL] [Abstract][Full Text] [Related]
33. Biosynthesis of platelet-activating factor and its 1O-acyl analogue by liver fat-storing cells. Pinzani M; Carloni V; Marra F; Riccardi D; Laffi G; Gentilini P Gastroenterology; 1994 May; 106(5):1301-11. PubMed ID: 8174891 [TBL] [Abstract][Full Text] [Related]
34. Consumption of plant extract supplement reduces platelet activating factor-induced platelet aggregation and increases platelet activating factor catabolism: a randomised, double-blind and placebo-controlled trial. Gavriil L; Detopoulou M; Petsini F; Antonopoulou S; Fragopoulou E Br J Nutr; 2019 May; 121(9):982-991. PubMed ID: 30940217 [TBL] [Abstract][Full Text] [Related]
35. Platelet-activating factor: mediator of the third pathway of platelet aggregation? A study in three patients with deficient platelet-activating factor synthesis. Sturk A; Schaap MC; ten Cate JW; Heymans HS; Schutgens RB; Przyrembel H; Borst P J Clin Invest; 1987 Feb; 79(2):344-50. PubMed ID: 3805272 [TBL] [Abstract][Full Text] [Related]
36. Transient activation of the acetyltransferase necessary for paf-acether biosynthesis in thrombin-activated platelets. Coëffier E; Ninio E; Le Couedic JP; Chignard M Br J Haematol; 1986 Apr; 62(4):641-51. PubMed ID: 3964558 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of platelet-activating factor biosynthesis via the acetyltransferase by arachidonic and oleic acids in ionophore A23187-stimulated bovine neutrophils. Remy E; Lenoir G; Houben A; Vandesteene C; Remacle J Biochim Biophys Acta; 1989 Sep; 1005(1):87-92. PubMed ID: 2505852 [TBL] [Abstract][Full Text] [Related]
38. High-density lipoprotein inhibits the synthesis of platelet-activating factor in human vascular endothelial cells. Sugatani J; Miwa M; Komiyama Y; Ito S J Lipid Mediat Cell Signal; 1996 Jan; 13(1):73-88. PubMed ID: 8998599 [TBL] [Abstract][Full Text] [Related]
39. Biosynthesis of platelet-activating factor (PAF) in human polymorphonuclear leucocytes. The role of lyso-PAF disposal and free arachidonic acid. Garcia MC; Fernandez-Gallardo S; Gijon MA; Garcia C; Nieto ML; Sanchez Crespo M Biochem J; 1990 May; 268(1):91-8. PubMed ID: 1693077 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and release of platelet-activating factor and eicosanoids in human endothelial cells induced by different agonists. Cabré F; Tost D; Suesa N; Gutiérrez M; Ucedo P; Mauleón D; Carganico G Agents Actions; 1993 Mar; 38(3-4):212-9. PubMed ID: 8213348 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]